Abbott Recalls Synthroid Tablets Due to Defective Bottle Bottoms
Abbott Laboratories is recalling 53,448 bottles of Synthroid (levothyroxine sodium) 50 mcg tablets nationwide due to a defect in the bottle bottom that may affect tablet stability.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a potential impact on tablet stability due to a container defect, which fits the criteria for moderate severity without reported injuries.
Plain-English summary
Abbott Laboratories is recalling 53,448 bottles of Synthroid (levothyroxine sodium) Tablets USP, 50 mcg, 90-Count. The recall affects bottles with the code 18265A8 and an expiration date of 09/20/2013. The product was distributed nationwide.
The recall was initiated because a number of the bottles have a localized thin wall defect on the bottom. This defect may potentially impact the stability of the tablets contained within the bottles.
Consumers who have this specific product should stop using it and contact their healthcare provider or pharmacist for further instructions. The recall is classified as FDA Class II.
The recalled product
- Product
- SYNTHROID (LEVOTHYROXINE SODIUM)
- Brand
- SYNTHROID
- Manufacturer
- Abbott Laboratories
- Category
- Drug — Prescription Medication
- Affected units
- 53,448
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 18265A8
- Exp 09/20/2013
UPCs (10)
- 0300747149902
- 0300747068197
- 0300744341194
- 0300745182192
- 0300747070190
- 0300747069903
- 0300749296192
- 0300743727906
- 0300747148905
- 0300746624905
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Abbott Laboratories under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · SYNTHROID
- HighSynthroid Levothyroxine Tablets Recalled for Incorrect Barcode Labeling
FDA (Drugs) · 2023-11-15
- ModerateAbbott Recalls Synthroid Tablets Due to Incorrect Strength Labeling
FDA (Drugs) · 2013-01-09
- ModerateAbbott Recalls Synthroid Tablets Due to Defective Bottle Bottoms
FDA (Drugs) · 2012-10-03
- ModerateAbbott Recalls Synthroid Tablets Due to Container Wall Defect
FDA (Drugs) · 2012-10-03
Same manufacturer · Abbott Laboratories
See all →- HighChemistry analyzer control modules recalled over software that may give erroneous results
FDA (Devices) · 2025-12-24
- HighHematology analyzers recalled because saturation flags may not be applied
FDA (Devices) · 2025-11-19
- HighCELL-DYN Ruby hematology analyzer system expiration date validation
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby Hematology Analyzer Expiration Date Software Defect
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby hematology analyzer expiration date software defect
FDA (Devices) · 2025-04-30
Same hazard · container defect
See all →- HighOphthalmic solution recalled for defective container with lodged spike
FDA (Drugs) · 2024-08-21
- ModeratePEG-3350 Oral Solution Recalled for Defective Non-Sealed Pouches
FDA (Drugs) · 2024-08-14
- ModerateAsmanex (Mometasone Furoate) Recalled Due to Defective Container
FDA (Drugs) · 2024-06-19
- HighTimolol Maleate ophthalmic solution recalled for defective container cap nozzle
FDA (Drugs) · 2024-05-15
- HighPotassium Chloride Injection Recalled Due to Pinhole Container Defects
FDA (Drugs) · 2024-03-20